Joël Richard, PhD, is Head of Technical and Pharmaceutical Operations at MedinCell. Before that he was Senior Vice-President, Peptides, at Ipsen.
He has more than 25 years’ experience in industrial R&D, including several global senior positions in various biotech and pharma companies. Dr Richard He globally led all the CMC development activities of both injectable peptide products and oral small molecules, including APIs and drug products, with major franchises in Oncology, Endocrinology and Neurology.
Dr Richard graduated from Ecole Normale Supérieure in Cachan, France. He gained a PhD in Materials Science from the University of Paris, France. Dr Richard has focused his research activity on new formulation and drug delivery technologies, especially for injectable protein and peptide formulations. Dr Richard has published 65 peer-reviewed scientific papers, eight book chapters and two review editorials in various fields (colloids and interfaces, drug delivery, supercritical fluids, protein formulations, sustained-release formulations etc). He is the author of more than 100 international communications and 53 patent families.